A Novel Interleukin-10 Dna Mucosal Delivery System Attenuates Intestinal Inflammation in a Mouse Model
Inflammatory bowel diseases (IBD) describe a group of complex intestinal disorders characterized by inflammation in the gastrointestinal tract. Current treatments for IBD include the use of antiinflammatory drugs; furthermore, recombinant lactic acid bacteria have been used as a therapeutic vehicle...
Main Authors: | S. Del Carmen, M. Zurita-Turk, F. Alvarenga Lima, J.S. Coelho Dos Santos, S.Y. Leclercq, J.-M. Chatel, V. Azevedo, A. De Moreno De Leblanc, A. Miyoshi, J.G. Leblanc |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-09-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100308 |
Similar Items
-
The role of interleukin-33 in mucosal inflammation and fibrosis
by: Li, Dong
Published: (2014) -
Immune system in the intestine and mucosal inflammation
by: O'Mahony Liam
Published: (2011-08-01) -
Interleukin-4 Receptor α Subunit Deficiency Alleviates Murine Intestinal Inflammation In Vivo Through the Enhancement of Intestinal Mucosal Barrier Function
by: Ai Hertati, et al.
Published: (2020-10-01) -
Data on changes to mucosal inflammation and the intestinal microbiota following dietary micronutrients in genetically susceptible hosts
by: J.F. Pierre, et al.
Published: (2018-10-01) -
Autophagy: roles in intestinal mucosal homeostasis and inflammation
by: Sabah Haq, et al.
Published: (2019-02-01)